GGrantIndex
Sort

261,768 grants matching gene therapy

Molecular Therapies for Cystic Fibrosis Lung Disease

$2,265,385
Paul B McCray · University Of Iowa · P01 · FY2024 · HL

Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study

$2,265,244
Susan Abushakra · Alzheon, Inc. · R01 · FY2024 · AG

Intracellular delivery and targeting of nanoparticles

$2,265,000
Christine K Payne · Georgia Institute Of Technology · DP2 · FY2009 · OD

Understanding/ Treating Neuropsychiatric Symptoms of Pediatric Physical Illness

$2,265,000
Eva M Szigethy · University Of Pittsburgh At Pittsburgh · DP2 · FY2007 · OD

BIOLOGY OF HEMATOPOIETIC STEM CELLS

$2,264,933
Fred Hutchinson Cancer Research Center · P50 · FY2003 · HL

SPORE in Prostate Cancer

$2,264,776
Samuel R Denmeade · Johns Hopkins University · P50 · FY2025 · CA

Endothelial Metabolism and Redox Imbalance in Vascular Disease

$2,264,097
Tohru Fukai · Augusta University · P01 · FY2025 · HL

Endothelial Metabolism and Redox Imbalance in Vascular Disease

$2,264,097
Tohru Fukai · Augusta University · P01 · FY2024 · HL

Role Of Neuropeptides And Biogenic Amines In Stress and Brain Inflammation

$2,263,494
Juan M Saavedra · National Institute Of Mental Health · Z01 · FY2007 · MH

Radiation and checkpoint blockade for cancer immune therapy

$2,263,439
Robert H Vonderheide · University Of Pennsylvania · P01 · FY2022 · CA

Role of Pluripotency Factors in Pluripotent Stem Cells, Development and Disease

$2,263,386
Guang Hu · National Institute Of Environmental Health Sciences · ZIA · FY2018 · ES

HPV: Biology, Clinical Significance and Epidemiology

$2,263,372
Denise A. Galloway · Fred Hutchinson Cancer Research Center · P01 · FY2008 · CA

Understanding the Origins of Early COPD

$2,263,283
Fernando J Martinez · Weill Medical Coll Of Cornell Univ · R01 · FY2021 · HL

Diagnosis, Pathophysiology And Molecular Biology of Pheochromocytoma and Paraganglioma

$2,262,733
Karel Pacak · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2020 · HD

HEAL: Probe/Drug Lead Production

$2,262,666
Matthew Hall · National Center For Advancing Translational Sciences · ZIA · FY2020 · TR

PPG - Gene Therapy for Cystic Fibrosis Lung Disease

$2,262,564
Paul B McCray · University Of Iowa · P01 · FY2011 · HL

Development of a cell replacement therapy to treat retinal degenerative blindness

$2,262,500
Budd A Tucker · University Of Iowa · DP2 · FY2010 · OD

Molecular Genetics of Endocrine Tumors and Related Disorders

$2,262,473
Constantine A. Stratakis · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2013 · HD

Predicting the emergence of antibiotic resistance through multi-omics approaches and Immune System-surveillan

$2,262,413
Tim Van Opijnen · Boston College · U01 · FY2018 · AI

Chinese American Eye Study

$2,262,150
Rohit Varma · University Of Southern California · U10 · FY2010 · EY

Translational Research in Breast Cancer

$2,262,139
C Kent Osborne · Baylor College Of Medicine · P50 · FY2012 · CA

Pre-clinical Translational Research Facility

$2,262,089
Mark Gilbert · Division Of Basic Sciences - Nci · ZIC · FY2024 · CA

Molecular Genetics of Endocrine Tumors and Related Disorders

$2,261,967
Constantine A. Stratakis · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2021 · HD

Nano Approaches to Modulate Host Cell Response for Cancer Therapy

$2,261,936
Leaf Huang · Univ Of North Carolina Chapel Hill · U54 · FY2015 · CA

Translational and epigenetic profiling of cell types associated with addiction

$2,261,558
Nathaniel Heintz · Rockefeller University · RC2 · FY2009 · DA